Delayed initiation or reduced initial dose of calcineurin-inhibitors for kidney transplant recipients-Reference-Cited by-同舟云学术

Delayed initiation or reduced initial dose of calcineurin-inhibitors for kidney transplant recipients

Published:2022-11-16 Issue:11 Volume:2022 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Oliveras Laia¹,Lopez-Vargas Pamela²,Melilli Edoardo¹,Codina Sergi¹,Royuela Ana³,Coloma López Ana¹,Favà Alexandre¹,Manonelles Anna¹,Cruzado Josep M¹,Montero Nuria¹

Affiliation:

1. Department of Nephrology; Hospital Universitari de Bellvitge; L'Hospitalet de Llobregat Spain

2. Centre for Kidney Research; The Children's Hospital at Westmead; Westmead Australia

3. Department of Biostatistics; Biomedical Sciences Research Institute, Hospital Universitario Puerta de Hierro-Majadahonda, CIBERESP; Majadahonda Spain

Publisher

Wiley

Subject

Pharmacology (medical)

Reference35 articles.

1. A randomized trial of basiliximab with three different patterns of cyclosporin A initiation in renal transplant from expanded criteria donors and at high risk of delayed graft function;Andrés;Clinical Transplantation,2009

2. A randomized trial comparing renal function in older kidney transplant patients following delayed versus immediate tacrolimus administration;Andrés;Transplantation,2009

3. Delayed graft function in kidney transplantation;Bahl;Current Opinion in Organ Transplantation,2019

4. Tacrolimus: 20 years of use in adult kidney transplantation. What we should know about its nephrotoxicity;Bentata;Artifical Organs,2020

5. A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine a in adult renal transplant recipients;Charpentier;Transplantation,2003